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Lactic dehydrogenase virus (LDV) associated with transplantable line Ib lymphocytic 
leukemia in C58iWm mice, K36 lymphocytic leukemia in AKRiJ mice, and the Gardner 
lymphosarcoma in C3HIHeJ mice elicited a fatal neuroparalytic disease when injected ip into 
7- to g-month-old X-irradiated indicator C58 mice. LDV associated with the WEHI-3B 
line of transplantable myelomonocytic leukemia or the Harding-Passey transplantable 
myeloma in BALB/c mice failed to elicit the disease. Recipients of such tumor extracts 
were immune to rechallenge by line Ib-associated LDV. Tumor lines free of LDV failed 
to elicit the disease or immunize recipient mice to line Ib LDV challenge. The Plagemann 
(P-LDV), Riley (R-LDV), and Notkins (N-LDV) strains of LDV were less neuropathogenic 
than the line Ib-derived strain (Ib-LDV). Indicator C58 mice that survived infection by the 
P-LDV, R-LDV, and N-LDV strains were immune to rechallenge by Ib-LDV. Antiserum 
prepared in young C58 mice to Ib-LDV or R-LDV protected indicator C58 mice from 
Ib-LDV challenge. These results show that a common viral contaminant of transplantable 
tumors and virus stocks that ordinarily is not pathogenic elicits a fatal neurologic disease 
in genetically susceptible, immunosuppressed, C58 mice. 
When young immunocompetant C58 mice 
are immunized with X-irradiated (10,000 R) 
syngeneic line Ib malignant cells (Ib cells) a 
strong protective response to transplanted 
leukemia is elicited (1) that is mediated by 
Thy 1.2+, Ia+, T cells (2). However, when 
normal C58 mice 9 or more months of age 
receive a similar injection of X-irradiated Ib 
cells (3 ) they develop a fatal paralytic 
neurologic disease characterized by an 
inflammatory destruction of motor neurons 
that is confined largely to the brain stem and 
cord (4). Paralysis begins at about 9 days 
after the injection of X-irradiated cells, 
reaches a peak at 13 to 1’7 days, and 
parallels motor neuron destruction (4). The 
histopathology of the disease is distinctive 
(4) in that the demyelination seen in other 
neurotropic mouse virus infections is absent 
and the white matter and peripheral nerves 
are free of lesions. The flaccid paralysis seen 
is not accompanied by ataxia, tremors, or 
seizures. In the naturally susceptible C58 
1 To whom reprint requests should be addressed. 
strain susceptibility correlates (5, 6) with 
an age-dependent loss in T-cell functions. 
The disease can be elicited in young C58 or 
AKR mice (5) providing that they are 
immunosuppressed by X irradiation or 
drugs 1 day before the ip injection of 
X-irradiated Ib cells. The common inbred 
strains of mice (5-r) are not susceptible 
whether they are young or old or immuno- 
suppressed or not. Extensive efforts to 
implicate a conventional mouse virus or a 
neuropathogenic C-type virus in the disease 
(reviewed in Ref. (6 ), or to demonstrate an 
autoimmune basis for the disease, were 
unsuccessful (reviewed in Ref. (7’)). These 
results suggested that either a constituent 
of Ib cells was neuroparalytic to C58 mice 
or that some unconventional virus asso- 
ciated with line Ib cells was the neuro- 
pathogenic agent. After the realization 
(6, 7) that only genetically susceptible 
immunosuppressed mice were suitable for 
tests, virus assays were repeated using 
highly susceptible X-irradiated C58 mice as 
indicator animals. We report here that LDV 
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infection is an essential etiologic factor in 
the pathogenesis of this multifactorial dis- 
ease in the naturally susceptible C58 strain. 
As discussed below, coinfection by N-tropic 
C-type retroviruses in mouse strains per- 
missive for N-tropic retrovirus replication 
appears to be of equal etiologic importance 
(see Ref. (7) and unpublished data). 
For virus assays lo8 viable Ib cells 
prepared from the spleens of C58 mice 
moribund from transplanted line Ib 
leukemia were suspended in 0.5 ml of 
Hanks’ balanced salt solution (HBSS), 
sonicated (10 kHz at 25 mA, 4”) using a 
Ratheon low-intensity DF 101 oscillator, 
and centrifuged at 100,000 g for 2 hr. The 
supernatant fluid was filtered through a 
0.22-p” filter, diluted in HBSS to contain 
10 pg protein/ml, and injected intra- 
peritoneally (ip) as passage 1 into 6-month- 
old C58 mice that had received 600 R of 
whole-body X irradiation 24 hr previously. 
Details of methodology are given in Ref. 
(5). For the second passage spleen cell 
suspensions were prepared from mice that 
were moribund from paralytic disease (14 to 
17 days after the initial injection), pooled, 
and a cell-free extract was prepared as 
described for passage 1. All subsequent 
serial passages were done in the same way. 
Table 1 shows that a self-replicating 




Serial incidence of Cumulative 
passage” paralysis or death” dilution 
1 616 10-e 
2 616 10-U 
3 717 10-1H 
4 3113 lo-“4 
5 717 10-X 
6 717 10-X 
(’ Cell-free filtrates were prepared as described in 
the text from spleen cells obtained from 6-month-old 
X-irradiated C58 mice moribund from histologically 
confirmed motor neuron disease. 
* Mice developed paralytic disease within 15 to 20 
days after the ip injection (1 ml) of each spleen cell 
extract. 
was implicated in the etiology of the dis- 
ease. These results confirmed our pre- 
liminary findings (7) and those reported 
concurrently by Martinez et al. (8). 
Since Ib cells are known to contain an 
abundance of C-type virus particles (3 >, and 
might be contaminated with other mouse 
viruses as well (9, lo), it was essential to 
implicate the detected virus in the patho- 
genesis of the disease. Therefore a spec- 
trum of tumors was assayed to determine 
whether the neuropathogenic virus was 
unique to Ib cells or ubiquitous in tumor 
cell lines. Because susceptibility to the dis- 
ease correlated (5-7) with the suscep- 
tibility of the C58 (H-2”) and AKRiJ 
(H-2k) strains to spontaneous leukemia, 
tumors were selected for study that were 
lymphoid neoplasms of the H-2k haplotype. 
Two H-2” nonlymphoid tumors were used as 
controls. The high levels of neuropathogenic 
activity observed in the serum of C58 mice 
24 hr after the injection of Ib cells (6, 11 ), 
and unpublished studies by Martinez et al. 
(Ref. (8 ) and personal communication), 
suggested that LDV might be the neuro- 
pathogenic agent. The tumor cell lines listed 
in Table 2 therefore were tested both for 
their capacity to elicit paralytic disease in 
indicator C58 mice and for LDV activity. 
Sonicates of lo8 tumor cells were centrifuged 
at 3000 g for 10 min, the supernatant 
fluid was diluted lo-’ in HBSS, and 1 ml 
was injected ip into g-month-old indicator 
C58 mice that had received 600 R 24 hr 
previously. To detect LDV activity each 
tumor cell extract also was injected ip (1 ml) 
into 4- to 6-week-old BALB/c mice (5 mice/ 
assay). Five days later the plasma from 
individual mice was tested for lactic 
dehydrogenase (LDH) activity as described 
by Rowson and Mahy (12). A five-fold 
increase of LDH above normal levels was 
scored positive (+) for LDV infection. The 
results in Table 2 show that the three H-2k 
lymphoid tumors that elicited the disease 
were infected with LDV; the two H-Zk 
lymphoid tumors free of LDV did not. The 
two H-2d nonlymphoid tumors contaminated 
with LDV did not elicit the disease. The 
indicator mice that had received tumor 
extracts free of LDV (IbN and C58/J) were 
not immune to challenge by Ib cell extracts. 
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The mice that had received LDV-positive, 
nonlymphoid, H-2" tumors were immune to 
line Ib LDV challenge. These results in- 
dicated that either LDV strains differed 
markedly in their neuropathogenicity, or 
that something associated with the H-gk 
spleen cells of lymphoid tumors was 
required for LDV neuropathogenicity. 
To test directly whether LDV was 
neuropathogenic to g-month-old indicator 
C58 mice, strains of LDV virus were ob- 
tained that have been well characterized. 
Because our previous studies (Y’), and the 
data in Table 2, suggested that the C-type 
viruses abundant in C58 mice might have an 
effect on LDV neuropathogenicity, or that 
there might be a H-Zh haplotype association, 
virus stocks were prepared in both C58lWm 
(H-Zk) and BALB/cWm (H4fd) mice for 
comparative tests. LDV stock strains 
[kindly provided by Drs. P. G. Plagemann, 
Department of Microbiology, Univ. of 
Minnesota (P-LDV); Dr. Vernon Riley, 
Fred Hutchinson Cancer Research Center, 
Washington (R-LDV); and Dr. A. L. 
Notkins, National Institute of Dental 
Research, National Institute of Health, 
Bethesda, Md. (N-LDV)] and line Ib- 
derived virus (Ib-LDV) were passed three 
times serially in 2- to 3-month-old C58 
and BALB mice. Passages were made by 
the ip injection of blood plasma specimens 
(1 ml) at 24-hr intervals. All stocks had an 
ID,, titer of 10y- lO’“/ml plasma. The data in 
Table 3 established that the Ib-LDV strain 
was more neuropathogenic than the P-LDV, 
R-LDV, or N-LDV strains, and that the 
stocks of P-LDV, R-LDV, and N-LDV 
prepared in C58 mice were not markedly 
more neuropathogenic than those made in 
TABLE 2 
INDUCTION OF PARALYTIC DISEASE IN INDICATOR C58 MICE BY TUMOR CELL EXTRACTS 
Tumor 
cell line” Type of tumor 
Haplotype 








disease in mice 
challenged with 
Ib cell extracts’ 
Line Ib Lymphocytic 
leukemia 
C58iWm (H#) 20120 t 
K36 Lymphocytic 
leukemia 
AKRiJ (H-2”) 5112 + O/7 
Gardner 
IbN 
Lymphosarcoma C3HIHeJ(H-Zk) 12/12 i 




C58iWm (H-P) o/9 - 919 





Melanoma BALBicWm (H-P) 0114 + 0114 
u The K36, Gardner, and C58/J tumor cell lines were obtained from EG & G Mason Research Institute, 
Worchester, Mass.; the remaining tumors were stock Michigan lines. IbN is an in vitro permanent line derived 
from Ib cells. 
0 Assays were done in X-irradiated (550 R) 7- to g-month-old indicator C58 mice that were observed for 
paralysis for 60 days; paralytic disease was confirmed histopathologically. The mean time in days for paralysis 
was: Line Ib = 15; K36 = 2’7; Gardner = 20. 
’ Mice that were free of disease over a 60-day observation period were challenged by the ip injection 
(1.0 ml) of line Ib cell extract 24 hr after they received 600 R of whole-body X irradiation. 
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TABLE 3 
COMPARATIVE NEUROPATHOGENICITY OF 
LDV STRAINS 
Incidence of 
Mouse disease in 
strain Mean mice chal- 
LDV for Incidence days to lenged with 
strain” passage of disease” paralysis’ Ib-LDV” 
Ib-LDV C58 13113 15 
BALB 13113 15 
P-LDV C58 10/1(3 23 216 
BALB 5115 26 Oil0 
R-LDV C58 6114 26 O/8 
BALB 5113 27 018 
N-LDV C58 12115 28 O/3 
BALB XI15 25 l/7 
” Ib-LDV = LDV from Ib cells; P-LDV = Plagemann 
strain of LDV; R-LDV = Riley strain of LDV; N-LDV 
= Notkins strain of LDV. 
” Each 9-month-old indicator C58 mouse received 600 R 
24 hr before the ip injection (1 ml) of 10’ ID.,,, of each stock 
virus. 
’ Mice were held for a GO-day observation period. 
” Mice free of disease 60 days after initial virus injection 
received 600 R and then were rechallenged with 10’ ID,,, of 
Ib-LDV. Control mice similarly held were fully susceptible 
to Ib-LDV-induced paralytic disease. 
BALB mice. Mice that did not develop 
neurologic disease after P-LDV, R-LDV, 
or N-LDV infection were immune to 
Ib-LDV challenge. 
Studied were done as described pre- 
viously (4) to document that the histo- 
pathology of the paralytic disease elicited by 
LDV virus infection was the same as that 
elicited by line Ib cell-associated virus. 
Representative paralyzed and disease-free 
mice were killed, the vertebral column 
removed in toto, and fixed in 10% (v/v) 
formalin-phosphate-buffered (pH 7.2) 
0.85% NaCl solution. The entire column was 
decalcified and transverse slices of the spi- 
nal cord and vertebrae were taken at five 
levels as described previously (4). Sections 
were embedded in parafin, sectioned, and 
stained with hematoxylin and eosin. The 
histopathology of the disease elicited by 
LDV infection did not differ in any major 
way from that described previously (4 ). 
Mice free of clinical signs of disease did not 
have lesions suggestive of subclinical 
paralysis. 
Serum protection tests were carried out 
to further confirm that LDV elicited neuro- 
paralytic disease in indicator C58 mice. 
Antiserum was prepared from 2-month-old 
immunocompetent C58 mice that had re- 
ceived a single ip injection (1 ml) of 
lo7 ID,, of Ib-LDV or R-LDV. One month 
later blood was collected (retroorbital 
bleeding, 20 mice/group), the serum 
separated, diluted 1:lO in 0.85% NaCl solu- 
tion (saline), and the immunoglobulins were 
precipitated with 45% saturation with 
ammonium sulfate. The precipitate and 
supernatant were dialyzed against saline 
(4”) for 24 hr with a saline change every 
6 hr. The volumes of both fractions were 
adjusted (HBSS) to the original serum 
volume. Antisera diluted either 1:lO or 1:25 
were injected iv (1 ml) into ‘I-month-old 
indicator C58 mice that received 600 R 24 hr 
later. All mice were challenged 24 hr later 
by ip injection of lo7 ID,, of Ib-LDV. 
Table 4 shows that the immunoglobulin 
fraction obtained from the serum of mice 
immunized with either Ib-LDV or R-LDV 
TABLE 4 
PROTECTION OF INDICATOR MICE FROM PARALYSIS 
BY IMMUNE SERUM 
LDV strain used 
to immunize 
Z-month-old 











Ib-LDV whole serum 5132 
immunoglobulins 3113 
supernatant 9110 
R-LDV whole serum l/12 
immunoglobulins 0113 0117 
supernatant 0112 10114 
Normal serum whole serum 15115 
” Serum fractions were injected iv (1.0 ml) into 
7-month-old indicator C58 mice. The next day they 
received 600 R of whole-body X irradiation. Twenty- 
four hours later they were challenged by the ip 
injection of lo7 ID,, of Ib-LDV. Mice were scored for 
paralysis over a 30-day period. 
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protected Ib-LDV-challenged mice from 
the disease. 
The evidence implicating LDV as an 
essential etiologic factor in the age-de- 
pendent paralytic neurologic disease that 
occurs in the naturally susceptible C58 
&rain is reasonably sound. LDV derived 
from Ib cells elicited the disease; Ib cells 
freed of LDV by growth in vitro (IbN) did 
not. C58 mice inoculated with LDV strains 
of low neuropathogenicity were immune 
when challenged with Ib-LDV. Serum from 
mice immunized with Ib-LDV or R-LDV 
protected indicator mice from Ib-LDV 
challenge. Well-characterized strains of 
LDV elicited the specific disease syndrome 
as proven by the appropriate histologic 
studies. The peak activity of virus in 
serum was associated with a 1.17 g/ml 
buoyant density fraction in CsCl gradients, 
serum titers 24 hr after infection were of 
tkle order of lo”-10”’ ID,,jml, and LDV 
strains of low neuropathogenicity (R-LDV) 
interfered with the neuropathogenicity of 
Ib-LDV (unpublished data). These results 
are consistent with the conclusion that the 
neuropathogenic agent was in fact LDV. 
Our results are in accord with those re- 
ported in parallel studies by Martinez et al. 
(Ref. (8) and personal communication). 
In the described experimental model, as 
in other multifactorial diseases such as 
those that occur in NZB mice (13), a 
number of etiologic factors must converge 
to elicit pathologic changes. It is within this 
context that LDV is to be considered a 
neuropathogenic agent in the naturally 
susceptible C58 strain. We now have 
identified (reviewed in 7) four conditions 
that must be met for neuroparalytic disease 
to occur in the naturally susceptible C58 
strain. The first is an age-dependent loss 
in T-cell functions (6, 7) that includes the 
failure to develop a protective response to 
line Ib transplantable leukemia (3), a 
decrease in the capacity of the spleen cells 
from old mice to undergo a blastogenic 
response to T-cell mitogens (14) and to 
produce antibodies to sheep erythrocytes 
(5). We report here the second require- 
ment, viz, infection by neuropathogenic 
strains of LDV. Two additional factors 
are of equivalent importance. Detailed 
genetic studies have shown (Ref. (7) and 
unpublished data) that susceptibility is not 
H-2 linked but appears to be regulated 
primarily by the Fv-1 locus (15). Moreover, 
only those mouse strains that contain 
multiple copies of N-tropic C-type retro- 
viruses in their genomes (16 ) and that are 
permissive for N-tropic retrovirus replica- 
tion (Fv-1”‘“) appear to be susceptible. 
Other genetic factors also are involved in 
natural susceptibility or resistance (un- 
published data). Such results suggest that 
dual infection by LDV and N-tropic C-type 
retroviruses is required to elicit the disease. 
The paradox is that both C-type viruses (3) 
and LDV (8) are abundant in the central 
nervous system of C58 mice as well as in 
most other tissues. Since neither LDV nor 
C-type viruses ordinarily are cytopathic, it 
is not clear whether motor neuron destruc- 
tion results from sequential or dual infection 
by these viruses or is mediated immuno- 
logically. The complexities of these 
problems are discussed in the cogent 
review by Oldstone et a,i. (17). Neverthe- 
less, the findings reported here suggest two 
considerations of possible importance for 
future work: that the use of immunosup- 
pressed genetically susceptible animals may 
aid in the detection of viruses in the slowly 
progressive neurologic diseases of sus- 
pected virus etiology; and that in some of 
these diseases infection by a common 
ubiquitous virus combined with endogenous 
virus infection may elicit a specific disease 
syndrome in a genetically susceptible host. 
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